NewLink Genetics Corp (NASDAQ:NLNK)
| 16.68 Data as of May 17 |  +0.40 / +2.46%Today’s Change | 10.60 Today|||52-Week Range 18.00 | +33.44% Year-to-Date |
Latest NLNK News | Press Releases
No recent news for NewLink Genetics Corp.
Today’s Trading
| Previous close | 16.28 |
| Today’s open | 16.32 |
| Day’s range | 16.21 - 17.41 |
| Volume | 777,513 |
| Average volume (3 months) | 144,724 |
| Market cap | $427.1M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | +62.42% |
| Earnings growth (this year) | -22.14% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -9.88% |
| P/E ratio | NM |
| Price/Sales | 153.97 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HITKHi-Tech Pharmacal Co... | +0.83 | +2.64% |
| PBTHPROLOR Biotech Inc | +0.15 | +2.37% |
| NDZNordion Inc | +0.06 | +0.83% |
| SCMPSucampo Pharmaceutic... | +0.04 | +0.42% |
Data as of 4:04pm ET, 05/17/2013
Financials
| Next reporting date | August 13, 2013 |
| EPS forecast (this quarter) | -$0.32 |
| Annual revenue (last year) | $1.7M |
| Annual profit (last year) | -$23.3M |
| Net profit margin | -1,382.39% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, Chief Executive & Scientific Officer Charles J. Link, Jr., MD |
President, Chief Operating & Medical Officer Nicholas N. Vahanian, MD, MBA |
Corporate headquarters Ames, Iowa |
Forecasts
